Aktuellt
SENASTE
Eurobio will cover France, Benelux, Germany, Switzerland, and the UK. Eurobio has some 290 employees and an active presence in oncology based on in vitro diagnostics testing. The agreement is distinctly positive, and we expect the collaboration to proceed into an active sales stage in the second half of 2025. Eurobio is a resourceful company and the agreement covers 60% of the European DiviTum market.
LÄS MER
